Du Plessis
Impact in
- Pharmaceutical Science top 1%
- Advanced Drug Delivery Systems
- Advancements in Transdermal Drug Delivery
- Drug Solubulity and Delivery Systems
- Microbiology top 2%
- Antimicrobial Peptides and Activities
Papers in
-
- Advancements in Transdermal Drug Delivery 8
- Advanced Drug Delivery Systems 7
- Drug Solubulity and Delivery Systems 6
- Co-authors
- Johannes F. Wentzel (10 shared papers)Angélique Lewies (6 shared papers)Josias H. Hamman (8 shared papers)Jeanetta du Plessis (5 shared papers)Minja Gerber (4 shared papers)Awie F. Kotzé (12 shared papers)Abel J. Bronkhorst (3 shared papers)Etresia van Dyk (3 shared papers)
- Journals
- International Journal of Pharmaceutics (5 papers)Biochimie (3 papers)Molecules (3 papers)Pharmaceutics (2 papers)Biomedical Materials (2 papers)
- Partner nations
- South AfricaUnited StatesHong Kong
In The Last Decade
Du Plessis
59 papers receiving 1.6k citations
Peers
Comparison fields: 5 of 124
- Pharmaceutical Science 247
- Microbiology 241
- Molecular Medicine 69
- Cancer Research 194
- Pharmacology 103
Countries citing papers authored by Du Plessis
This map shows the geographic impact of Du Plessis's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Du Plessis with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Du Plessis more than expected).
Fields of papers citing papers by Du Plessis
This network shows the impact of papers produced by Du Plessis. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Du Plessis. The network helps show where Du Plessis may publish in the future.
Co-authors
The 25 scholars most cited alongside Du Plessis, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 61 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2014 | 225 | |
| 2 | 2015 | 146 | |
| 3 | 2018 | 146 | |
| 4 | 2015 | 86 | |
| 5 | 2017 | 78 | |
| 6 | 2017 | 56 | |
| 7 | 2016 | 52 | |
| 8 | 2013 | 52 | |
| 9 | 2017 | 49 | |
| 10 | 2015 | 48 | |
| 11 | 2008 | 44 | |
| 12 | 2014 | 40 | |
| 13 | 2010 | 38 | |
| 14 | 2011 | 36 | |
| 15 | 2015 | 36 | |
| 16 | 2016 | 34 | |
| 17 | 2012 | 33 | |
| 18 | 2009 | 33 | |
| 19 | 2015 | 28 | |
| 20 | 2007 | 28 |
About Du Plessis
Du Plessis is a scholar working on Molecular Biology, Pharmaceutical Science, Public Health, Environmental and Occupational Health, Microbiology and Biomedical Engineering, having authored 61 papers that have together received 1.6k indexed citations. Recurring topics across this work include Advancements in Transdermal Drug Delivery (8 papers), Antimicrobial Peptides and Activities (7 papers), Advanced Drug Delivery Systems (7 papers), Drug Solubulity and Delivery Systems (6 papers), Malaria Research and Control (6 papers), 3D Printing in Biomedical Research (5 papers), Vector-Borne Animal Diseases (2 papers) and Antibiotics Pharmacokinetics and Efficacy (2 papers). The work is most often cited by research in Pharmaceutical Science (247 citations), Microbiology (241 citations), Molecular Medicine (69 citations), Cancer Research (194 citations) and Pharmacology (103 citations). Du Plessis has collaborated with scholars based in South Africa, United States and Hong Kong. Frequent co-authors include Johannes F. Wentzel, Angélique Lewies, Josias H. Hamman, Jeanetta du Plessis, Minja Gerber, Awie F. Kotzé, Abel J. Bronkhorst, Etresia van Dyk, Piet J. Pretorius and Janine Aucamp. Their work appears in journals such as International Journal of Pharmaceutics, Biochimie, Molecules, Pharmaceutics and Biomedical Materials.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.